Movement Alert｜DRINDA Intraday Rise 12.06% in Regular Trading, Photovoltaic Rebound and Second Growth Curve Expectations Continue

Market Focus11-09

On November 9, DRINDA rose 12.06% in regular trading, trading at HK$14.97, with turnover of HK$27.0411 million.

The move followed recent market discussion around a continued rebound in photovoltaic shares and expectations for the company’s second growth curve. Recent market coverage said investors remain focused on bottom-repair trading in the photovoltaic sector, while institutional commentary highlighted the potential for higher shipments from the Turkey production base and progress in satellite energy, whole-satellite manufacturing, and space-computing constellation initiatives.

Background figures show the company reported third-quarter revenue of RMB2.042 billion, up 1.17% year on year, while attributable net profit was a loss of RMB175 million. Earlier disclosures also showed first-nine-month revenue of RMB5.223 billion and attributable net loss of RMB428 million, indicating core operations are still under pressure even as the market trades on marginal improvement and new-business optionality.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment